Sponsors (3)
The bill expands Medicare coverage and payment flexibility to increase access to in-home IVIG and support home-based providers, at the trade-off of higher Medicare/taxpayer costs, potential revenue loss for infusion centers, and elevated safety risks without clearer oversight.
Medicare beneficiaries who need IVIG can get coverage for in-home IVIG administration, increasing access to treatment at home and reducing their exposure to infections from clinic visits.
Medicare's ability to vary payments for in-home IVIG can enable higher reimbursements that support home-based care delivery and strengthen capacity for providers and healthcare workers to deliver IVIG at home.
Expanding Medicare payments for in-home IVIG is likely to increase program spending and therefore raise costs for taxpayers.
The bill does not specify stronger quality controls or oversight for home IVIG administration, which could raise risks of inconsistent administration and safety problems for beneficiaries receiving treatment at home.
Shifting more IVIG care to the home could reduce patient volume and revenue for outpatient clinics and infusion centers.
Based on analysis of 2 sections of legislative text.
Expands Medicare to allow coverage and a payment variance for intravenous immune globulin administered in a patient's home.
Expands Medicare so that intravenous immune globulin (IVIG) can be covered and paid for when given in a patient’s home, and gives Medicare authority to vary payment to account for in‑home administration. The bill amends the Social Security Act to add coverage language and payment‑variance authority for in‑home IVIG, but the specific statutory text that would set eligibility, payment rates, or provider rules is not included in the provided summary. Implementation will require Medicare (CMS) to issue rules or guidance and adjust claims/payment processes; the overall impact on beneficiary access, provider payments, and program spending will depend on those future details.
Introduced February 7, 2025 by Adrian Smith · Last progress February 7, 2025